πŸ‡ΊπŸ‡Έ FDA
Patent

US 12312334

Quinoxaline compounds and uses thereof

granted A61KA61K9/0053A61P

Quick answer

US patent 12312334 (Quinoxaline compounds and uses thereof) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K9/0053, A61P, A61P25/00, A61P29/00